Formulation and Optimization of Monolithic Fixed-Dose Combination of Metformin HCl and Glibenclamide Orodispersible Tablets

Figure 6

Contour plot (a) and response surface plot (b) of PEG 6000 and crospovidone on disintegration time.

(a)

(b)